Sarah P. Cecil

Sarah P. Cecil appears in our data through filings on Yield10 Bioscience, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 10 November 2006 to 1 April 2016.

In open-market terms, that means 1 purchase worth €5,446 on one side and 2 sales worth €152k on the other. The net balance comes to €146k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 2 option exercises.

The record was last updated on 5 April 2016 with a share grant (€8,810) in Yield10 Bioscience, Inc. The most recent open-market purchase was published on 13 November 2006, 7,301 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.